Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,247 | -63,556 | -43,799 | -49,366 | -43,289 |
| Depreciation Amortization | 2,690 | 2,298 | 1,172 | 1,204 | 1,378 |
| Other Working Capital | -5,865 | 1,997 | 1,529 | 185 | 1,586 |
| Other Operating Activity | 2,665 | 10,014 | 7,447 | 8,472 | 2,457 |
| Operating Cash Flow | $-53,757 | $-49,246 | $-33,650 | $-39,505 | $-37,869 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,056 | -650 | -369 | -137 | -2,810 |
| Investing Cash Flow | $-1,056 | $-650 | $-369 | $-137 | $-2,810 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,415 | 3,043 | 1,649 | 1,075 | 409 |
| Common Stock Issued | 840 | 54,592 | 100,457 | 29,036 | 2 |
| Other Financing Activity | -691 | -1,412 | 0 | 0 | -17 |
| Financing Cash Flow | $16,563 | $56,223 | $102,106 | $30,111 | $395 |
| Exchange Rate Effect | -3,002 | 808 | -202 | -3,017 | 817 |
| Beginning Cash Position | 127,881 | 118,250 | 56,805 | 66,914 | 104,978 |
| End Cash Position | 86,630 | 125,384 | 124,690 | 54,366 | 65,511 |
| Net Cash Flow | $-41,251 | $7,134 | $67,885 | $-12,548 | $-39,467 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,757 | -49,246 | -33,650 | -39,505 | -37,869 |
| Capital Expenditure | -1,056 | -650 | -369 | -137 | -2,810 |
| Free Cash Flow | -54,812 | -49,896 | -34,019 | -39,642 | -40,679 |